HSIC Company Profile and Key Details
NASDAQ : HSIC
Henry Schein
$78.05
0.6+0.77%
At Close 4:00 PM58.03
B-ESG ScoreESG Rating
Price Chart
Stock Price Today
Henry Schein, Inc. (HSIC) stock surged +0.77%, trading at $78.05 on NASDAQ, up from the previous close of $77.45. The stock opened at $76.97, fluctuating between $76.88 and $78.30 in the recent session.
Stock Snapshot
77.45
Prev. Close
8.89B
Market Cap
76.875
Day Low
23.58
P/E Ratio
3.31
EPS (TTM)
2.41
Cash Flow per Share
76.97
Open
113.92M
Number of Shares
78.3
Day High
98.55%
Free Float in %
28.16
Book Value
1.18M
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 08, 2026 | 76.97 | 78.31 | 76.88 | 78.05 | 1.14M |
| Jun 05, 2026 | 76.83 | 77.76 | 76.13 | 77.45 | 1.05M |
| Jun 04, 2026 | 76.97 | 77.53 | 76.20 | 76.30 | 1.35M |
| Jun 03, 2026 | 75.95 | 76.54 | 75.44 | 75.74 | 1.14M |
| Jun 01, 2026 | 76.04 | 77.04 | 75.74 | 76.40 | 1.29M |
| May 29, 2026 | 76.29 | 78.04 | 75.91 | 76.58 | 2.44M |
| May 28, 2026 | 74.79 | 76.91 | 74.68 | 76.32 | 989.69K |
| May 27, 2026 | 74.47 | 76.62 | 74.38 | 75.67 | 1.86M |
| May 26, 2026 | 74.25 | 74.51 | 73.60 | 73.90 | 1.23M |
| May 22, 2026 | 73.56 | 74.81 | 73.45 | 74.21 | 1.02M |
| May 21, 2026 | 72.55 | 73.79 | 71.66 | 73.50 | 1.01M |
| May 20, 2026 | 72.92 | 73.90 | 71.69 | 73.23 | 1.36M |
| May 19, 2026 | 72.38 | 73.86 | 72.00 | 72.92 | 1.49M |
| May 18, 2026 | 72.91 | 73.99 | 72.25 | 72.69 | 1.35M |
| May 15, 2026 | 72.76 | 73.31 | 71.50 | 72.72 | 3.1M |
| May 14, 2026 | 69.84 | 72.86 | 69.68 | 72.61 | 3.15M |
| May 13, 2026 | 69.67 | 70.84 | 68.84 | 69.45 | 1.28M |
| May 12, 2026 | 69.24 | 70.30 | 68.96 | 69.35 | 1.66M |
| May 11, 2026 | 70.95 | 71.27 | 68.70 | 68.99 | 2.07M |
| May 08, 2026 | 70.67 | 71.35 | 69.34 | 70.82 | 1.44M |
Contact Details
About Company
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Company Information
| Employees | 25000 |
| Beta | 0.85 |
| Sales or Revenue | $12.34B |
| 5Y Sales Change% | 0.092% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Distribution |
Stock Peers
Company Overview
Henry Schein, Inc. (NASDAQ:HSIC) closed at $78.05 USD, gaining $0.60 (0.77%) from the previous close of $77.45. The stock is currently mid-range between its 52-week high and low $61.95 and $89.29. With a market capitalization of about $8.89 billion, Henry Schein, Inc. is classified as a mid-cap and shows market-like volatility (beta ~0.82). Key stats such as the average daily volume over the past year has been around 1.36 million shares, in line with its 52-week average. Headquartered in Melville, NY, Henry Schein, Inc. operates in the Healthcare sector and the Medical - Distribution industry. Led by CEO Andrea Albertini, the company employs approximately 25,000 people and listed since November 03, 1995. Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services.
Technical Performance
Short-term trend indicators are bearishly aligned (SMA20 3.88%, SMA50 4.83%, SMA200 13.71%). The stock’s 14-day RSI is 58.13 (neutral), while the ATR of 2.72 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -8.76% below its high and over 34.53% above its low. Average 10-day trading volume of 1.19 million shares is below the 3-month average of 1.36 million, indicating normal recent market interest.
Valuation Metrics
Henry Schein, Inc. trades at a P/E ratio of 22.68, slightly below the S&P 500 average, with a price-to-sales ratio of 0.66 and a price-to-book ratio of 2.74 suggesting the stock is closer to book value. The P/FCF stands at 20.6, also above market averages.
Dividend & Fair Value
Henry Schein, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $68.72. This means the shares are trading above this model’s fair value.
Earnings & Analyst Outlook
Henry Schein, Inc. generated EPS of $3.27 over the past year. Five-year average earnings growth is 3.12%. Wall Street analysts project EPS growth of 9.17% annually over the next five years. The latest quarter delivered EPS of $1.32. The next quarter is forecast at $1.22. Next year's EPS is expected at $13.89. Analyst sentiment is neutral. Analyst rating data shows there are 14 Strong Buy ratings, 1 Buy ratings, 13 Hold ratings, 0 Sell rating and 3 Strong Sell ratings. Price targets range from $100.00 to $58.00. The high target offers 28.12% upside. The low target suggests -25.69% downside. The mean target is $81.48. This offers 4.39% upside. Henry Schein, Inc. earnings surprise history is a mixed track record. The quarter that ended May 05, 2026, missed forecasts by 10.0%. The prior quarter beat by 3.08%. Over the last six quarters, Apple has recorded several small beats. These include -3.25% in February 25, 2025.
Shareholding & Insider Activity
Henry Schein, Inc. has 121.27 million shares outstanding. The public float is 101.95 million shares, elevated short interest at 7.57% of float. This equals 7.96 million shares. The short ratio is 3.76 days. Institutional investors hold 115.27% of the float. Insiders own 0.87%. BERGMAN STANLEY M holds 383.80 thousand shares, BRESLAWSKI JAMES P has 209.56 thousand shares and PALADINO STEVEN has 144.62 thousand shares. Over the past six months, insider transactions show net selling. They sold 46.82 thousand shares across 7 transactions.
Financial & Profitability Overview
On valuation metrics, Henry Schein trades at a P/E of 22.68, P/S of 0.66 and P/B of 2.74. The current ratio is 1.36 and quick ratio is 0.75. Operationally, the company’s inventory turnover is 4.67 and cash conversion cycle is 84.54 days. Debt-to-equity is 1.15, supported by a cash flow-to-debt ratio of 0.15.
Quarterly Financial Highlights
The company ended the quarter with $171.00M in cash and short-term investments, a total debt of $2.74B, and net debt of $2.57B. Total assets were $10.57B, with equity of $5.15B. Financials further reflected stability, with operating cash flow of $500.00M, free cash flow of $313.00M, and capital expenditures of - $187.00M.
Price Forecast & Outlook
Our AI price prediction model suggests that Henry Schein, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.93%, with price expected at $81.90 by June 22, 2026, within a range of $79.93 to $83.93 3-Month Outlook: Projected rise of 50.34%, reaching $117.34 by September 03, 2026, with a range of $109.53 to $125.96. 1-Year Outlook: Projected loss of -2.88%, with price at $75.80 by June 08, 2027, within a range of $73.88 to $77.40.
Key Takeaways
Henry Schein, Inc. (NASDAQ:HSIC) shares are flat 2.84% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Henry Schein, Inc. trading at a premium to the broader market with a P/E of 22.68. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $81.66, suggesting 4.63% upside. Our AI forecast model points to short-term strength (4.93% over two weeks), a medium-term rise (50.34% over three months), and a longer-term loss (-2.88% over one year), with expected trading ranges indicating moderate volatility.
Frequently Asked Questions
What is the current Henry Schein, Inc. (HSIC) stock price?
Henry Schein, Inc. (NASDAQ: HSIC) stock price is $78.05 in the last trading session. During the trading session, HSIC stock reached the peak price of $78.30 while $76.88 was the lowest point it dropped to. The percentage change in HSIC stock occurred in the recent session was 0.77% while the dollar amount for the price change in HSIC stock was $0.60.
HSIC's industry and sector of operation?
The NASDAQ listed HSIC is part of Medical - Distribution industry that operates in the broader Healthcare sector. Henry Schein, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of HSIC?
Mr. Stanley M. Bergman
Executive Chairman & Chief Executive Officer
Mr. James P. Breslawski
Executive Vice Chairman & Pres
Mr. Steven Paladino
Executive Director
Mr. Michael Saul Ettinger
Executive Vice President & Chief Operating Officer
Mr. Ronald N. South
Senior Vice President & Chief Financial Officer
Mr. Christopher Pendergast
Senior Vice President & Chief Technology Officer
Graham Stanley
Vice President of Investor Relations & Strategic Fin. Project Officer
Ms. Olga Timoshkina
Vice President of Corporation Fin., Chief Accounting Officer & Corp. Controller
Mr. Walter Siegel
Senior Vice President & Chief Legal Officer
Mr. Bradford C. Connett
Chief Executive Officer of North America Distribution Group
Mr. Mark E. Mlotek
Executive Vice President, Chief Strategic Officer & Exec. Director
Executive Chairman & Chief Executive Officer
Mr. James P. Breslawski
Executive Vice Chairman & Pres
Mr. Steven Paladino
Executive Director
Mr. Michael Saul Ettinger
Executive Vice President & Chief Operating Officer
Mr. Ronald N. South
Senior Vice President & Chief Financial Officer
Mr. Christopher Pendergast
Senior Vice President & Chief Technology Officer
Graham Stanley
Vice President of Investor Relations & Strategic Fin. Project Officer
Ms. Olga Timoshkina
Vice President of Corporation Fin., Chief Accounting Officer & Corp. Controller
Mr. Walter Siegel
Senior Vice President & Chief Legal Officer
Mr. Bradford C. Connett
Chief Executive Officer of North America Distribution Group
Mr. Mark E. Mlotek
Executive Vice President, Chief Strategic Officer & Exec. Director
How HSIC did perform over past 52-week?
HSIC's closing price is 25.99% higher than its 52-week low of $61.95 where as its distance from 52-week high of $89.29 is -12.59%.
How many employees does HSIC have?
Number of HSIC employees currently stands at 25,000.
Link for HSIC official website?
Official Website of HSIC is: https://www.henryschein.com
How do I contact HSIC?
HSIC could be contacted at phone 631 843 5500 and can also be accessed through its website. HSIC operates from 135 Duryea Road, Melville, NY 11747, United States.
How many shares of HSIC are traded daily?
HSIC stock volume for the day was 1.18M shares. The average number of HSIC shares traded daily for last 3 months was 1.36M.
What is the market cap of HSIC currently?
The market value of HSIC currently stands at $8.89B with its latest stock price at $78.05 and 113.92M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep